Screener
Harmony Biosciences Holdings, Inc. HRMY Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Other current liabilities | 11,907 | 4,957 |
| Total current liabilities | 217,340 | 252,132 |
| NONCURRENT LIABILITIES: | ||
| Long-term debt, net | 138,814 | 143,663 |
| Other noncurrent liabilities | 5,321 | 5,618 |
| Total noncurrent liabilities | 144,135 | 149,281 |
| TOTAL LIABILITIES | 361,475 | 401,413 |
| COMMITMENTS AND CONTINGENCIES (Note 13) |
Item 1. Financial Statements
FAQ
- What is Harmony Biosciences Holdings, Inc.'s long-term debt?
- Harmony Biosciences Holdings, Inc. (HRMY) reported long-term debt of $138.81M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s long-term debt changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s long-term debt decreased by 12.2% year-over-year, from $158.18M to $138.81M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s long-term debt?
- Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s long-term debt has grown at a -5.9% compound annual growth rate (CAGR), from $194.25M to $143.66M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Harmony Biosciences Holdings, Inc.'s long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude